Juliane Siebourg-Polster

Juliane Siebourg-Polster

Auto-generated profile, based on publicly available information

Juliane Siebourg-Polster

Roche Innovation Center, pRED, Roche, Basel, Switzerland

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2020 in Clinical Pharmacology & Therapeutics
Verified
Journal Article
Open access
PDF file
SBSolveig Badillo
Solveig Badillo
BBBalazs Banfai
Balazs Banfai
FBFabian Birzele
Fabian Birzele
IDIakov I. Davydov
Iakov I. Davydov
LHLucy Hutchinson
Lucy Hutchinson
JZJitao David Zhang
Jitao David Zhang
In the last few years, machine learning (ML) and artificial intelligence have seen a new wave of publicity fueled by the huge and ever‐increasing amount of data and computational power as well as the discovery of improved learning algorithms. However, the idea of a computer learning some abstract concept from data and applying them to yet unseen situations is not new and has been around at least since the 1950s. Many of these basic principles are very familiar to the pharmacometrics and clinical pharmacology community. In this paper, we want to introduce the foundational ideas of ML to this community such that readers obtain the essential tools they need to understand publications on the topic. Although we will not go into the very details and theoretical background, we aim to point readers to relevant literature and put applications of ML in molecular biology as well as the fields of pharmacometrics and clinical pharmacology into perspective.

27 April 2018 in Movement Disorders
Verified
Journal Article
Open access
PDF file
FLFlorian Lipsmeier
Florian Lipsmeier
KTKirsten I. Taylor
Kirsten I. Taylor
TKTimothy Kilchenmann
Timothy Kilchenmann
DWDetlef Wolf
Detlef Wolf
ASAlf Scotland
Alf Scotland
MLMichael Lindemann
Michael Lindemann
Background: Ubiquitous digital technologies such as smartphone sensors promise to fundamentally change biomedical research and treatment monitoring in neurological diseases such as PD, creating a new domain of digital biomarkers.Objectives: The present study assessed the feasibility, reliability, and validity of smartphone‐based digital biomarkers of PD in a clinical trial setting.Methods: During a 6‐month, phase 1b clinical trial with 44 Parkinson participants, and an independent, 45‐day study in 35 age‐matched healthy controls, participants completed six daily motor active tests (sustained phonation, rest tremor, postural tremor, finger‐tapping, balance, and gait), then carried the smartphone during the day (passive monitoring), enabling assessment of, for example, time spent walking and sit‐to‐stand transitions by gyroscopic and accelerometer data.Results: Adherence was acceptable: Patients completed active testing on average 3.5 of 7 times/week. Sensor‐based features showed moderate‐to‐excellent test‐retest reliability (average intraclass correlation coefficient = 0.84). All active and passive features significantly differentiated PD from controls with P < 0.005. All active test features except sustained phonation were significantly related to corresponding International Parkinson and Movement Disorder Society–Sponsored UPRDS clinical severity ratings. On passive monitoring, time spent walking had a significant (P = 0.005) relationship with average postural instability and gait disturbance scores. Of note, for all smartphone active and passive features except postural tremor, the monitoring procedure detected abnormalities even in those Parkinson participants scored as having no signs in the corresponding International Parkinson and Movement Disorder Society–Sponsored UPRDS items at the site visit.Conclusions: These findings demonstrate the feasibility of smartphone‐based digital biomarkers and indicate that smartphone‐sensor technologies provide reliable, valid, clinically meaningful, and highly sensitive phenotypic data in Parkinson's disease. © 2018 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.

14 December 2010 in Nature Communications
Verified
Journal Article
Open access
PDF file
AOAndreas Otto
Andreas Otto
JBJörg Bernhardt
Jörg Bernhardt
HMHanna Meyer
Hanna Meyer
MSMarc Schaffer
Marc Schaffer
FHFlorian-Alexander Herbst
Florian-Alexander Herbst
DBDörte Becher
Dörte Becher
Functional genomics of the Gram-positive model organism Bacillus subtilis reveals valuable insights into basic concepts of cell physiology. In this study, we monitor temporal changes in the proteome, transcriptome and extracellular metabolome of B. subtilis caused by glucose starvation. For proteomic profiling, a combination of in vivo metabolic labelling and shotgun mass spectrometric analysis was carried out for five different proteomic subfractions (cytosolic, integral membrane, membrane, surface and extracellular proteome fraction), leading to the identification of ∼52% of the predicted proteome of B. subtilis. Quantitative proteomic and corresponding transcriptomic data were analysed with Voronoi treemaps linking functional classification and relative expression changes of gene products according to their fate in the stationary phase. The obtained data comprise the first comprehensive profiling of changes in the membrane subfraction and allow in-depth analysis of major physiological processes, including monitoring of protein degradation.

10 July 2024 in Nature
Verified
Journal Article
Open access
PDF file
MBMiriam Bosch
Miriam Bosch
NKNina Kallin
Nina Kallin
SDSainitin Donakonda
Sainitin Donakonda
JZJitao David Zhang
Jitao David Zhang
HWHannah Wintersteller
Hannah Wintersteller
PKPercy A. Knolle
Percy A. Knolle
Chronic hepatitis B virus (HBV) infection affects 300 million patients worldwide1,2, in whom virus-specific CD8 T cells by still ill-defined mechanisms lose their function and cannot eliminate HBV-infected hepatocytes3–7. Here we demonstrate that a liver immune rheostat renders virus-specific CD8 T cells refractory to activation and leads to their loss of effector functions. In preclinical models of persistent infection with hepatotropic viruses such as HBV, dysfunctional virus-specific CXCR6+ CD8 T cells accumulated in the liver and, as a characteristic hallmark, showed enhanced transcriptional activity of cAMP-responsive element modulator (CREM) distinct from T cell exhaustion. In patients with chronic hepatitis B, circulating and intrahepatic HBV-specific CXCR6+ CD8 T cells with enhanced CREM expression and transcriptional activity were detected at a frequency of 12–22% of HBV-specific CD8 T cells. Knocking out the inhibitory CREM/ICER isoform in T cells, however, failed to rescue T cell immunity. This indicates that CREM activity was a consequence, rather than the cause, of loss in T cell function, further supported by the observation of enhanced phosphorylation of protein kinase A (PKA) which is upstream of CREM. Indeed, we found that enhanced cAMP–PKA-signalling from increased T cell adenylyl cyclase activity augmented CREM activity and curbed T cell activation and effector function in persistent hepatic infection. Mechanistically, CD8 T cells recognizing their antigen on hepatocytes established close and extensive contact with liver sinusoidal endothelial cells, thereby enhancing adenylyl cyclase–cAMP–PKA signalling in T cells. In these hepatic CD8 T cells, which recognize their antigen on hepatocytes, phosphorylation of key signalling kinases of the T cell receptor signalling pathway was impaired, which rendered them refractory to activation. Thus, close contact with liver sinusoidal endothelial cells curbs the activation and effector function of HBV-specific CD8 T cells that target hepatocytes expressing viral antigens by means of the adenylyl cyclase–cAMP–PKA axis in an immune rheostat-like fashion.

1 June 2009
Verified
Conference Paper
Closed access
JBJörg Bernhardt
Jörg Bernhardt
SFStefan Funke
Stefan Funke
MHMichael Hecker
Michael Hecker
JSJuliane Siebourg
Juliane Siebourg
We investigate the use of Voronoi Treemaps to visualize complex biological data from gene expression analysis in conjunction with hierarchical classifications like Gene Ontology or KEGG Orthology.

22 December 2014 in BMC Genomics
Verified
Journal Article
Open access
PDF file
PRPauli Rämö
Pauli Rämö
ADAnna Drewek
Anna Drewek
CACécile Arrieumerlou
Cécile Arrieumerlou
NBNiko Beerenwinkel
Niko Beerenwinkel
HBHouchaima Ben-Tekaya
Houchaima Ben-Tekaya
CDChristoph Dehio
Christoph Dehio
Large-scale RNAi screening has become an important technology for identifying genes involved in biological processes of interest. However, the quality of large-scale RNAi screening is often deteriorated by off-targets effects. In order to find statistically significant effector genes for pathogen entry, we systematically analyzed entry pathways in human host cells for eight pathogens using image-based kinome-wide siRNA screens with siRNAs from three vendors. We propose a Parallel Mixed Model (PMM) approach that simultaneously analyzes several non-identical screens performed with the same RNAi libraries.